HeartSciences annual return on equity
2024
2025
2026
HeartSciences Return on Equity (ROE) Growth & History (HSCS)
HeartSciences's return on equity was −4,239.90% for fiscal 2026.
View full HeartSciences company overviewHeartSciences annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-04-30 | −4,239.90% | −4006.86 pp |
| 2025 | 2025-04-30 | −233.04% | −58.02 pp |
| 2024 | 2024-04-30 | −175.02% | — |
HeartSciences quarterly return on equity
Q2.23
Q3.23
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q4 2026 | 2026-04-30 | −191.16% | +19.13 pp |
| Q3 2026 | 2026-01-31 | −58.09% | +29.31 pp |
| Q2 2026 | 2025-10-31 | −64.20% | −22.33 pp |
| Q1 2026 | 2025-07-31 | −122.82% | −91.86 pp |
| Q4 2025 | 2025-04-30 | −210.29% | −187.14 pp |
| Q3 2025 | 2025-01-31 | −87.41% | −40.33 pp |
| Q2 2025 | 2024-10-31 | −41.86% | — |
| Q1 2025 | 2024-07-31 | −30.97% | — |
| Q4 2024 | 2024-04-30 | −23.15% | — |
| Q3 2024 | 2024-01-31 | −47.07% | +278.38 pp |
| Q3 2023 | 2023-01-31 | −325.45% | — |
| Q2 2023 | 2022-10-31 | −91.01% | — |
HeartSciences return on equity trends
Between the periods ended 2024-04-30 and 2026-04-30, HeartSciences's return on equity decreased from −175.02% to −4,239.90%, a change of −4064.87 percentage points. The latest reported quarter, Q4 2026, shows −191.16%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HeartSciences source filings ↗